Systemic sclerosis and lupus: points in an interferon-mediated continuum. - Wikidata - wikimedia - TriplyDB

Systemic sclerosis and lupus: points in an interferon-mediated continuum.

Systemic sclerosis and lupus: points in an interferon-mediated continuum.

http://www.wikidata.org/entity/Q33889629

about

Current perspectives on systems immunology approaches to rheumatic diseases.Gene expression profiling offers insights into the role of innate immune signaling in SSc Recent advances in the genetics of systemic sclerosis: toward biological and clinical significance Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy Dissecting the heterogeneity of skin gene expression patterns in systemic sclerosis Linkage of type I interferon activity and TNF-alpha levels in serum with sarcoidosis manifestations and ancestry Identification of cadherin 11 as a mediator of dermal fibrosis and possible role in systemic sclerosis.Systems biology approaches reveal a specific interferon-inducible signature in HTLV-1 associated myelopathy.Whole-blood gene expression profiling in ankylosing spondylitis shows upregulation of toll-like receptor 4 and 5 Genomic signatures characterize leukocyte infiltration in myositis muscles.Lymphotoxin-LIGHT pathway regulates the interferon signature in rheumatoid arthritis.The systemic lupus erythematosus IRF5 risk haplotype is associated with systemic sclerosis.Experimentally-derived fibroblast gene signatures identify molecular pathways associated with distinct subsets of systemic sclerosis patients in three independent cohorts.Sclerotic-type chronic GVHD of the skin: clinical risk factors, laboratory markers, and burden of disease Molecular basis for antagonistic activity of anifrolumab, an anti-interferon-α receptor 1 antibody Plasmacytoid dendritic cells and C1q differentially regulate inflammatory gene induction by lupus immune complexes.DNA methylation similarities in genes of black South Africans with systemic lupus erythematosus and systemic sclerosis.Pathogenesis of Systemic Sclerosis.Novel identification of the IRF7 region as an anticentromere autoantibody propensity locus in systemic sclerosis IRF5 polymorphism predicts prognosis in patients with systemic sclerosis Human asthma phenotypes: from the clinic, to cytokines, and back again Toll-like receptors as therapeutic targets for autoimmune connective tissue diseases Correlation of interferon-inducible chemokine plasma levels with disease severity in systemic sclerosis.The role of type 1 interferon in systemic sclerosis.A systemic sclerosis and systemic lupus erythematosus pan-meta-GWAS reveals new shared susceptibility loci New insight on the Xq28 association with systemic sclerosis.Implication of IL-2/IL-21 region in systemic sclerosis genetic susceptibility.Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities.Presence of an interferon signature in individuals who are anti-nuclear antibody positive lacking a systemic autoimmune rheumatic disease diagnosis.Toll-like receptors in rheumatic diseases: are we paying a high price for our defense against bugs?Capturing the heterogeneity in systemic sclerosis with genome-wide expression profiling.Unraveling the genetic component of systemic sclerosis.What does global gene expression profiling tell us about the pathogenesis of systemic sclerosis?Innate immunity in systemic sclerosis pathogenesis.Current frontiers in systemic sclerosis pathogenesis.Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis.Cytokines in the immunopathology of systemic sclerosis.Clinical Trial Design Issues in Systemic Sclerosis: an Update.Basal Activation of Type I Interferons (Alpha2 and Beta) and 2'5'OAS Genes: Insights into Differential Expression Profiles of Interferon System Components in Systemic Sclerosis Systematic approach to understanding the pathogenesis of systemic sclerosis.

P2860

Q27687400-4422DE36-2EC2-418D-9D3E-6244F3344F39 Q28083733-36AB35A8-23D5-47A0-AFC5-CDC2F7536379 Q28088499-88BBBAD2-8CBD-46BC-8808-ACD7A57B2F5B Q29417020-70C3F2ED-8860-4FA0-A336-C74C6244B30E Q30845649-85AF24BA-14F8-4E1B-890D-30A58A35A318 Q34110737-8A7E2A2B-FD67-4DF6-B934-8DC49E5CF454 Q34133158-F07CC4A3-A610-4C5E-B3CD-692BD63662FE Q34145669-4C40E4FB-B11B-432F-8704-EE4B2D49181D Q34458987-57CB6DFB-3DB5-484C-A47B-098F6FE0823D Q34484782-6350FD0E-9D51-4835-B9CE-C37822D55B1F Q34535634-9ECBF495-AACA-4550-A13D-FF5FC674FA2E Q34571170-707C13FF-D63A-4946-86E3-4FFA457855DC Q34995163-174BCFF4-3243-41C5-95E3-4398084BEC1E Q35483838-3AF73A97-8A87-4D5A-833A-C18F9F74F925 Q35545957-F9742DD7-3BCD-400A-9334-FEA7278F6F27 Q35616122-6D102908-5677-4C80-82F3-F50DCC86363F Q35624618-7E417A6A-3EBB-4866-84B2-FD9E3A226A5A Q35693212-7BB2927C-BFBA-4823-8324-8CF33497A455 Q36014384-51D3B731-9488-4E5E-B747-3E619427950F Q36032649-D9823E57-8C54-4034-9165-C6A754070E4E Q36079964-0E0C31B1-CEAF-45A4-9C84-B197B6394DEA Q36940639-7B1F3540-CC40-41F1-B900-61C86D518AE3 Q36942366-CB27C6F7-524C-4CEE-99D6-C07A00EE8E6E Q37150404-34C90969-A723-4B90-BA17-6851E27F0D62 Q37153818-0D596D79-4130-4FA8-88EE-3E2024254149 Q37282406-7DDF22FA-509A-4CBC-97AA-F6F72078028C Q37460609-92B972F9-863B-41E3-8F6D-04F1A5EA1518 Q37638268-1CDAE601-5C1B-4D36-A938-E710523864D8 Q37673362-853C0B80-B3D7-426D-8CCE-0796D7CD792E Q37868069-B946411B-4350-469A-AFB7-7001DAFF1CB0 Q37905787-8EF635B0-8A80-485A-9711-78E4EB4F8F43 Q37973287-57C9FDEA-646D-4DA2-9C8C-94CEA1234B1F Q38141638-2885EFD1-5299-4FF5-9FB5-AF57A6C9D987 Q38161937-9D339C40-6644-4D85-8C54-D799BBB9F4A9 Q38364957-C1DD7AA1-EAD3-492B-8B6D-157B4227BECA Q38367681-B40A2670-07E8-40F7-927A-87E5B625D93E Q38543692-F89AF196-1166-48DA-8A65-5BA4FDD1787C Q38825869-BB7DA4A3-5877-4C3B-9A24-8F26DC27E603 Q38909742-AF1A4D0D-F528-4A04-82FF-8944B6FBB6D4 Q39029340-C9C23DF2-4C10-4E43-9CB7-DAA517D781E4

P2860

Systemic sclerosis and lupus: points in an interferon-mediated continuum.

http://www.wikidata.org/entity/Q33889629

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Systemic sclerosis and lupus: points in an interferon-mediated continuum.

@ast

Systemic sclerosis and lupus: points in an interferon-mediated continuum.

@en

type

label

Systemic sclerosis and lupus: points in an interferon-mediated continuum.

@ast

Systemic sclerosis and lupus: points in an interferon-mediated continuum.

@en

prefLabel

Systemic sclerosis and lupus: points in an interferon-mediated continuum.

@ast

Systemic sclerosis and lupus: points in an interferon-mediated continuum.

@en

P1433

Q33889629-99BB305E-28AC-4E3F-A57E-235E08B4FA84

P1476

Q33889629-4205B1CD-B989-4106-A9F3-18A76197D0E4

P2093

Q33889629-047C1800-4A90-4B40-BB57-0A9F26E826B0

Q33889629-56385173-90A3-4736-B430-6D2B125BF168

Q33889629-59109551-541D-480E-88D5-C9CBE15F0EA6

Q33889629-5C47FD5D-60E3-41C7-9922-2D667FBFCF78

Q33889629-9625EB9E-DCC0-4CB4-83CD-9A7EF510EFD4

Q33889629-B4BA2D35-372F-46B2-B55E-4E9096480841

Q33889629-C95437F0-6ED0-4D68-B864-E5E400FCED19

Q33889629-CE4AF4C4-9D2B-4CDA-A027-25ADAD08C34C

Q33889629-D11C1240-CF96-4957-B624-379ADE12B22E

Q33889629-FBD73068-FE7B-413F-8A15-A1F034B3FAC6

P2860

Q33889629-00B80719-5826-47AF-9F34-6D4EDC21205E

Q33889629-0AEF955B-04EC-4D4F-A5B6-5B1B37546F45

Q33889629-0EB5D736-4C6F-40E2-A6C6-C8F719566E5C

Q33889629-16B28695-0D98-4FF2-B175-83484781C4AA

Q33889629-1DBAD3D3-4EC0-4502-971E-51736DED7CD4

Q33889629-33A56224-37AC-4151-9DB6-E12166726D3E

Q33889629-3843EA07-B0EA-4C1C-BD88-D39DA513368B

Q33889629-3CC26FBA-8B64-481B-A264-F9AD49C02262

Q33889629-47E75458-9886-47CA-A6A5-7A916660F6D8

Q33889629-4C6E2024-23CB-4643-86CD-6A8FFCCCA601

P304

Q33889629-322ACA23-76C4-4B1F-89EA-0EF981DB1090

P31

Q33889629-A4907BB7-9217-45BA-AFE8-C5F45846AFD9

P356

Q33889629-35B262B2-2CE7-425B-BF94-BE4C98012926

P433

Q33889629-3ADBFC8B-0FFE-4BC7-8FD2-F36516BF2996

P478

Q33889629-56E7E12D-286C-4A11-AB44-F218FD5E1B35

P50

Q33889629-2E474F35-0CAC-4971-998D-5A1F66EE1860

Q33889629-D5339B33-C868-4E39-A996-AA31FF86EDF2

Q33889629-E8116896-57D7-44D7-80A4-45F56F41B06A

P577

Q33889629-2B31FFB7-6A18-4C19-8E45-8095F3B537F4

P5875

Q33889629-F4BB84DD-E171-4B3C-BC6C-5965B54BDAD2

P698

Q33889629-A0757EFF-4168-4010-BD2E-DD2695E33EE0

P932

Q33889629-C9599FF0-0CE2-45F2-AB4C-4BE32C16BDC9

P356

P1433

Arthritis & Rheumatology

P1476

Systemic sclerosis and lupus: points in an interferon-mediated continuum.

@en

P2093

Filemon K Tan

http://www.w3.org/2001/XMLSchema#string

Frank C Arnett

http://www.w3.org/2001/XMLSchema#string

Julio Charles

http://www.w3.org/2001/XMLSchema#string

Kairav R Shah

http://www.w3.org/2001/XMLSchema#string

Maureen D Mayes

http://www.w3.org/2001/XMLSchema#string

Michael Fischbach

http://www.w3.org/2001/XMLSchema#string

Nancy Oommen

http://www.w3.org/2001/XMLSchema#string

Sandeep K Agarwal

http://www.w3.org/2001/XMLSchema#string

Shervin Assassi

http://www.w3.org/2001/XMLSchema#string

Terry A McNearney

http://www.w3.org/2001/XMLSchema#string

P2860

Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus

Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus

A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus

Association of the PTPN22 R620W polymorphism with anti-topoisomerase I- and anticentromere antibody-positive systemic sclerosis

The 1982 revised criteria for the classification of systemic lupus erythematosus

Interferon and granulopoiesis signatures in systemic lupus erythematosus blood

The nature of the principal type 1 interferon-producing cells in human blood

Molecular subsets in the gene expression signatures of scleroderma skin.

Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes.

Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy.

P304

589-598

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ART.27224

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

62

http://www.w3.org/2001/XMLSchema#string

P50

Damien Chaussabel

John D Reveille

P577

2010-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41175649

http://www.w3.org/2001/XMLSchema#string

P698

20112391

http://www.w3.org/2001/XMLSchema#string

P932

2879587

http://www.w3.org/2001/XMLSchema#string